Резултати
eNauka >
Rezultati >
Current level of evidence for improvement of antidepressant efficacy andtolerability by pharmacogenomic-guided treatment: A Systematic reviewand meta-analysis of randomized controlled clinical trials
| Naziv: | Current level of evidence for improvement of antidepressant efficacy andtolerability by pharmacogenomic-guided treatment: A Systematic reviewand meta-analysis of randomized controlled clinical trials | Autori: | Milosavljević, Filip   ; Molden, Espen; Ingelman-Sundberg, Magnus; Jukić, Marin |
Godina: | 2024 | Publikacija: | European Neuropsychopharmacology | ISSN: | 1873-7862 0924-977X European Neuropsychopharmacology Pretraži identifikator |
Izdavač: | Elsevier B.V. | Tip rezultata: | Naučni članak | Kolacija: | vol. 81 str. 43-52 | DOI: | 10.1016/j.euroneuro.2024.01.005 | WoS-ID: | 001183811200001 | Scopus-ID: | 2-s2.0-85184919952 | PMID: | 38340605 | URI: | https://farfar.pharmacy.bg.ac.rs/handle/123456789/5593 https://enauka.gov.rs/handle/123456789/904704 |
Projekat: | The Swedish Research Council (grant 2021-02732) PsyCise - Utility of Plasma Drug Level Monitoring and Cyp2c19/Cyp2d6 Genotyping in Dose Personalization of Antidepressants and Antipsychotics The Swedish Brain Foundation (grant FO2021-0314) |
M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
